Company / Revenue
Amgen Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$36.8B
FY2025
5-year range
$26.0B / $36.8B
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#8 of 153
Health Care
What the data says
Among 153 Health Care companies, Amgen is in the top 5% for revenue. Revenue has increased for 6 consecutive years, from $23.4B in FY2019 to $36.8B in FY2025.
Based on SEC 10-K filings.
$36.8B in FY2025 with a 5-year CAGR of +7.6%. Top quartile in the Health Care sector.
Improved from $28.2B to $36.8B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +11.8%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 153This company $36.8B Sector average $4.5B
▼
+713.5% above sector average
Key checks
Key Insights
- Amgen's revenue has grown for 6 consecutive years.
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, revenue increased 10.0% year-over-year.
- Ranks #8 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.8B | +10.0% |
| FY2024 | $33.4B | +18.6% |
| FY2023 | $28.2B | +7.1% |
| FY2022 | $26.3B | +1.3% |
| FY2021 | $26.0B | +2.2% |
| FY2020 | $25.4B | +8.8% |
| FY2019 | $23.4B | -1.6% |
| FY2018 | $23.7B | +3.9% |
| FY2017 | $22.8B | -0.6% |
| FY2016 | $23.0B | +6.1% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026